Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1740-2025

IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Recall

IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Model Number: 830089.

FDA recall Class II

Ongoing

FDA lists this Class II recall for IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1740-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 7, 2025
FDA report date
May 14, 2025
Quantity in commerce
996 units (267 US, 729 OUS)
Distribution
See key details
FDA cause
Software in the Use Environment

What is being recalled?

IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Model Number: 830089.

Affected model & UDI checker

Search the exact identifiers published for Z-1740-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
830089IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x;Check source noticeNot specified
FDA code information

Model Number: 830089; Software Versions: 6x, 7.x, and 8.x; UDI-DIs: (01)00884838106970(11)211130(10)6.1.0.0 (Version 6.1.0.0), (01)00884838106970(11)220623(10)6.2.0.0 (Version 6.2.0.0), (01)00884838115378(11)221214(10)7.0.0.0 (Version 7.0.0.0), (01)00884838115378(11)230711(10)7.1.0.0 (Version 7.1.0.0), (01)00884838122000(11)240325(10)8.0.0.0 (Version 8.0.0.0).

View the original FDA recall notice

Why was this product recalled?

An issue was identified with the software when using the Echo Module of ISCV, the issue may result in missing or incomplete information in the report.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. take?

On April 7, 2025 URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. 1. Actions that should be taken by the customer / user in order to prevent risks for patients or users " Verify that text added into the report conclusion matches the data in the work area interpret sheet (Refer to Attachment A Screenshot 2) " You may continue to use your system(s) in accordance with the intended use and by following the recommendation above. " Circulate this notice to all users of this device so that they are aware of the potential issue. " Please retain this letter with your system(s) until a solution is installed on your system; ensure the letter is in a place likely to be seen/viewed. " Please review the workflows described in Attachment A and identify whether either workflow is currently in use, or planned to be used, at your facility. Please note your response in the attached customer response form. " If these are not planned to be used at this time, please contact Philips Informatics Customer Support and ensure that this correction is implemented before beginning to use these workflows. " Please complete and return the attached response form to Philips promptly and no later than 30 days from receipt of this letter via email to: [email protected]. 2. Actions planned by Philips to correct the problem Once all customer responses have been received, a Philips representative will contact customers who use or may use the affected workflows to schedule a time to install the software solution on your system(s) to resolve the issue (reference FCO-TBD). Please be assured that maintaining the highest level of safety and quality is our greatest priority. If you need any further information or support concerning this issue, please contact your local Philips representative: Philips Informatics Customer Support: 1-800-669-1328, Option 1. This notice has been reported to the appropriate Regulatory Agencies. Adverse reactions or quality problems experienced with the us

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology